Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Nov. 30, 2019	Nov. 30, 2018	Nov. 30, 2017
Operating activities
Net income	$ 702.7	$ 933.4	$ 477.4
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	158.8	150.7	125.2
Stock-based compensation	37.2	25.6	23.9
Noncash nonrecurring income tax benefit (related to enactment of the U.S. Tax Act)	0.0	(309.4)	0.0
Special charges and transaction and integration expenses	0.0	3.0	19.1
Amortization of inventory fair value adjustment associated with acquisition of RB Foods	0.0	0.0	20.9
(Gain) loss on sale of assets	(1.6)	(5.4)	1.3
Deferred income tax expense	20.9	40.1	24.1
Income from unconsolidated operations	(40.9)	(34.8)	(33.9)
Settlement of forward-starting interest rate swaps	0.0	0.0	(2.9)
Changes in operating assets and liabilities (net of effect of businesses acquired):
Trade accounts receivable	12.2	19.8	(13.0)
Inventories	(20.9)	(10.0)	44.6
Trade accounts payable	128.2	72.8	98.2
Other assets and liabilities	(81.5)	(91.8)	6.8
Dividends received from unconsolidated affiliates	31.7	27.2	23.6
Net cash provided by operating activities	946.8	821.2	815.3
Investing activities
Acquisitions of businesses (net of cash acquired)	0.0	(4.2)	(4,327.4)
Capital expenditures (including expenditures for capitalized software)	(173.7)	(169.1)	(182.4)
Other investing activities	2.7	14.8	1.5
Net cash used in investing activities	(171.0)	(158.5)	(4,508.3)
Financing activities
Short-term borrowings, net	41.0	305.5	(134.6)
Long-term debt borrowings	0.0	25.9	3,989.6
Payment of debt issuance costs	0.0	0.0	(7.7)
Long-term debt repayments	(447.7)	(797.9)	(272.7)
Proceeds from exercised stock options	90.9	78.2	29.5
Taxes withheld and paid on employee stock awards	(12.7)	(11.6)	(5.8)
Payment of contingent consideration	0.0	(2.5)	(19.7)
Purchase of minority interest	0.0	(13.0)	(1.2)
Issuance of common stock non-voting (net of issuance costs of $0.9)	0.0	0.0	554.0
Common stock acquired by purchase	(95.1)	(62.3)	(137.8)
Dividends paid	(302.2)	(273.4)	(237.6)
Net cash (used in) provided by financing activities	(725.8)	(751.1)	3,756.0
Effect of exchange rate changes on cash and cash equivalents	8.8	(1.8)	5.4
Increase (decrease) in cash and cash equivalents	58.8	(90.2)	68.4
Cash and cash equivalents at beginning of year	96.6	186.8	118.4
Cash and cash equivalents at end of year	$ 155.4	$ 96.6	$ 186.8